BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 112 filers reported holding BIOSCRIP INC in Q2 2016. The put-call ratio across all filers is 0.03 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $63,000 | -70.6% | 60,500 | -18.2% | 0.00% | – |
| Q3 2016 | $214,000 | +12.6% | 74,000 | -0.5% | 0.00% | – |
| Q2 2016 | $190,000 | +458.8% | 74,362 | +368.4% | 0.00% | – |
| Q1 2016 | $34,000 | +21.4% | 15,876 | +0.1% | 0.00% | – |
| Q4 2015 | $28,000 | -6.7% | 15,863 | 0.0% | 0.00% | – |
| Q3 2015 | $30,000 | -47.4% | 15,863 | +0.1% | 0.00% | – |
| Q2 2015 | $57,000 | +470.0% | 15,851 | +620.2% | 0.00% | – |
| Q1 2015 | $10,000 | +900.0% | 2,201 | +995.0% | 0.00% | – |
| Q4 2014 | $1,000 | 0.0% | 201 | 0.0% | 0.00% | – |
| Q3 2014 | $1,000 | -50.0% | 201 | 0.0% | 0.00% | – |
| Q2 2014 | $2,000 | +100.0% | 201 | 0.0% | 0.00% | – |
| Q1 2014 | $1,000 | -97.3% | 201 | -96.0% | 0.00% | – |
| Q4 2013 | $37,000 | -15.9% | 5,000 | 0.0% | 0.00% | – |
| Q3 2013 | $44,000 | -47.0% | 5,000 | 0.0% | 0.00% | – |
| Q2 2013 | $83,000 | – | 5,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
| DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
| Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
| NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
| KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
| First Washington CORP | 454,200 | $3,788,000 | 2.12% |
| GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
| ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
| True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |